Banks deliberate pros and cons of $30bn ChemChina loan
The Asian syndication of a jumbo loan to back China National Chemical Corp’s (ChemChina) acquisition of Syngenta is seeing interest from many international lenders in Asia. Banks are weighing the benefits of the borrower’s state ownership against the weakness of its financials on a standalone basis, writes Shruti Chaturvedi.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: